Baseline characteristics of patients treated for newly diagnosed BL in Lilongwe, Malawi, by initial treatment regimen
. | Total no. of patients . | CHOP (n = 22) . | More intensive regimen (n = 9) . | P . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. . | % . | Median . | Range . | Mean . | SD . | No. . | % . | Median . | Range . | Mean . | SD . | . | ||
Male sex | 31 | 15 | 68 | 6 | 67 | 1 | ||||||||
Age, y | 31 | 20 | 15-57 | 16 | 15-55 | .65 | ||||||||
Body mass index, kg/m2 | 26 | 18.9 | 4.9 | 17.9 | 1.5 | .65 | ||||||||
B symptoms | 31 | 13 | 59 | 7 | 78 | .43 | ||||||||
Ann Arbor stage III to IV | 31 | 18 | 82 | 6 | 67 | .38 | ||||||||
ECOG PS ≥2 | 31 | 13 | 59 | 3 | 33 | .25 | ||||||||
aaIPI | 28 | 1 | ||||||||||||
1 | 5 | 24 | 2 | 28 | ||||||||||
2 | 9 | 43 | 3 | 43 | ||||||||||
3 | 7 | 33 | 2 | 28 | ||||||||||
Central nervous system involvement | 31 | 5 | 23 | 0 | 0 | .27 | ||||||||
Bone marrow involvement | 21 | 3 | 21 | 1 | 14 | 1 | ||||||||
Abdominal disease | 31 | 14 | 64 | 6 | 67 | 1 | ||||||||
Bulky disease (>10 cm) | 20 | 11 | 73 | 4 | 80 | 1 | ||||||||
HIV positive | 31 | 9 | 41 | 3 | 33 | 1 | ||||||||
CD4 count, cells per μL | 12 | 130 | 29-605 | 238 | 39-272 | .78 | ||||||||
HIV viral load, detectable >400 copies per μL | 12 | 4 | 44 | 0 | 0 | .49 | ||||||||
White blood cells, ×109/L | 31 | 7.2 | 2.8-20.3 | 7.4 | 2.1-11.7 | .91 | ||||||||
Hemoglobin, g/dL | 31 | 11.0 | 1.6-14.8 | 9.9 | 7.7-11.7 | .13 | ||||||||
Platelets, ×109/L | 31 | 314 | 139-859 | 438 | 157-635 | .24 | ||||||||
Creatinine, mg/dL | 29 | 0.6 | 0.3-2.4 | 0.5 | 0.4-1.7 | .41 | ||||||||
Bilirubin, mg/dL | 28 | 0.4 | 0.2-2.0 | 0.4 | 0.2-1.4 | .72 | ||||||||
Albumin, g/dL | 22 | 3.7 | 2.7-5.8 | 3.4 | 2.3-4.4 | .38 | ||||||||
LDH ratio per ULN | 28 | 2.2 | 0.4-20 | 2.2 | 1.0-5.1 | .98 | ||||||||
LDH >2× ULN | 28 | 14 | 33 | 5 | 71 | 1.0 |
. | Total no. of patients . | CHOP (n = 22) . | More intensive regimen (n = 9) . | P . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. . | % . | Median . | Range . | Mean . | SD . | No. . | % . | Median . | Range . | Mean . | SD . | . | ||
Male sex | 31 | 15 | 68 | 6 | 67 | 1 | ||||||||
Age, y | 31 | 20 | 15-57 | 16 | 15-55 | .65 | ||||||||
Body mass index, kg/m2 | 26 | 18.9 | 4.9 | 17.9 | 1.5 | .65 | ||||||||
B symptoms | 31 | 13 | 59 | 7 | 78 | .43 | ||||||||
Ann Arbor stage III to IV | 31 | 18 | 82 | 6 | 67 | .38 | ||||||||
ECOG PS ≥2 | 31 | 13 | 59 | 3 | 33 | .25 | ||||||||
aaIPI | 28 | 1 | ||||||||||||
1 | 5 | 24 | 2 | 28 | ||||||||||
2 | 9 | 43 | 3 | 43 | ||||||||||
3 | 7 | 33 | 2 | 28 | ||||||||||
Central nervous system involvement | 31 | 5 | 23 | 0 | 0 | .27 | ||||||||
Bone marrow involvement | 21 | 3 | 21 | 1 | 14 | 1 | ||||||||
Abdominal disease | 31 | 14 | 64 | 6 | 67 | 1 | ||||||||
Bulky disease (>10 cm) | 20 | 11 | 73 | 4 | 80 | 1 | ||||||||
HIV positive | 31 | 9 | 41 | 3 | 33 | 1 | ||||||||
CD4 count, cells per μL | 12 | 130 | 29-605 | 238 | 39-272 | .78 | ||||||||
HIV viral load, detectable >400 copies per μL | 12 | 4 | 44 | 0 | 0 | .49 | ||||||||
White blood cells, ×109/L | 31 | 7.2 | 2.8-20.3 | 7.4 | 2.1-11.7 | .91 | ||||||||
Hemoglobin, g/dL | 31 | 11.0 | 1.6-14.8 | 9.9 | 7.7-11.7 | .13 | ||||||||
Platelets, ×109/L | 31 | 314 | 139-859 | 438 | 157-635 | .24 | ||||||||
Creatinine, mg/dL | 29 | 0.6 | 0.3-2.4 | 0.5 | 0.4-1.7 | .41 | ||||||||
Bilirubin, mg/dL | 28 | 0.4 | 0.2-2.0 | 0.4 | 0.2-1.4 | .72 | ||||||||
Albumin, g/dL | 22 | 3.7 | 2.7-5.8 | 3.4 | 2.3-4.4 | .38 | ||||||||
LDH ratio per ULN | 28 | 2.2 | 0.4-20 | 2.2 | 1.0-5.1 | .98 | ||||||||
LDH >2× ULN | 28 | 14 | 33 | 5 | 71 | 1.0 |